Abstract
In this issue of Clinical Cancer Research , Rajendran et al. ([1][1]) have assessed the value of pretherapy fluoromisonidazole (FMISO) positron emission tomography (PET) imaging, an indicator of tissue hypoxia, in predicting survival of 73 patients with head and neck cancers. In this study, the
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have